Cargando…
ODP289 A rare case of COVID-19 vaccine-associated pituitary apoplexy
BACKGROUND: The occurrences of pituitary apoplexy following COVID-19 vaccination had only been reported twice. We present the case of a 24-year-old female who developed pituitary apoplexy following the second dose of an AstraZeneca COVID-19 vaccine. CLINICAL CASE: A 24-year-old female presented with...
Autores principales: | Zainordin, Nur Aisyah, Muhamad Hatta, Sharifah Faradila Wan, Mumin, Nazimah Abdul, Ghani, Rohana Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625125/ http://dx.doi.org/10.1210/jendso/bvac150.999 |
Ejemplares similares
-
Pituitary apoplexy after COVID-19 vaccination: A case report
por: Zainordin, Nur Aisyah, et al.
Publicado: (2022) -
ODP618 The profile of patients with ACTH-secreting pituitary adenomas and subclinical pituitary apoplexy
por: Tatsi, Christina, et al.
Publicado: (2022) -
ODP326 Isolated Abducens Palsy as a Presenting Feature of Pituitary Apoplexy
por: Alam, Mustafa, et al.
Publicado: (2022) -
ODP331 Management and Long Term Outcomes in a Patient with Pituitary Apoplexy in Pregnancy
por: Nandam, Neeharika, et al.
Publicado: (2022) -
ODP298 Are there identifiable differences in pituitary adenoma width, extension, invasion, or cystic degeneration in subclinical compared to clinical pituitary apoplexy patients?
por: Heffernan-Marks, Ariella, et al.
Publicado: (2022)